Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hoelzer

Showing results (401-410 of 415) with videos related to

Pageof 42
Sort By:
Annals of Hematology|July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsH Goldschmidt, P Sonneveld, F W Cremer, et al.
Hematology/Oncology Clinics of North America|January 9, 2001
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)N Gökbuget, D Hoelzer, R Arnold, et al.
Bone Marrow Transplantation|October 27, 2009
Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALLS Giebel, B Stella-Holowiecka, M Krawczyk-Kulis, et al.
Annals of Hematology|May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemiaW K Hofmann, G Heil, C Zander, et al.
Leukemia|November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseR Arnold, G Massenkeil, M Bornhäuser, et al.
Medical and Pediatric Oncology|May 2, 2002
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study GroupsN L Ramakers-van Woerden, R Pieters, D Hoelzer, et al.
Blood|September 10, 1998
Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89W D Ludwig, H Rieder, C R Bartram, et al.
Annals of Hematology|November 9, 2002
Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemiaW K Hofmann, G Seipelt, S Langenhan, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2006
[Clinical research at the European LeukemiaNet]S Saussele, K Adam, A Hochhaus, et al.
Bone Marrow Transplantation|March 7, 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemiaJ R Passweg, P Tiberghien, J Y Cahn, et al.
Pageof 42

Showing results (401-410 of 415) with videos related to

Sort By:
Pageof 42
Annals of Hematology|July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsH Goldschmidt, P Sonneveld, F W Cremer, et al.
Hematology/Oncology Clinics of North America|January 9, 2001
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)N Gökbuget, D Hoelzer, R Arnold, et al.
Bone Marrow Transplantation|October 27, 2009
Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALLS Giebel, B Stella-Holowiecka, M Krawczyk-Kulis, et al.
Annals of Hematology|May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemiaW K Hofmann, G Heil, C Zander, et al.
Leukemia|November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseR Arnold, G Massenkeil, M Bornhäuser, et al.
Medical and Pediatric Oncology|May 2, 2002
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study GroupsN L Ramakers-van Woerden, R Pieters, D Hoelzer, et al.
Blood|September 10, 1998
Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89W D Ludwig, H Rieder, C R Bartram, et al.
Annals of Hematology|November 9, 2002
Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemiaW K Hofmann, G Seipelt, S Langenhan, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2006
[Clinical research at the European LeukemiaNet]S Saussele, K Adam, A Hochhaus, et al.
Bone Marrow Transplantation|March 7, 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemiaJ R Passweg, P Tiberghien, J Y Cahn, et al.
Pageof 42